TERT and Osteopenia: Taken together, systemic administration of SHED-EVs exerts a therapeutic effect in osteopenia by improving the microenvironmental modulating function of recipient BMMSCs through enhancement of Tert expression and telomerase activity by SHED-EV-transferred miRNA.